Chronic Idiopathic Constipation (CIC) Drugs Market TOC - Profshare

Chronic Idiopathic Constipation (CIC) Drugs Market by Product Type (Lubiprostone, Linaclotide) by Application/End User (Hospitals & Clinics, Ambulatory Surgical Centers, Long Term Care Centers) by Industry Analysis, Volume, Share, Growth, Challenges, Trends, and Forecast 2016

Report Description

Table of Contents

Report Inquiry

List of Tables

List of Figures

Table of Contents
    1 Market Overview
      1.1 Product Overview and Scope of Product
      1.2 Global Market of Chronic Idiopathic Constipation (CIC) Drugs

    2 Market Insights by Product Type
      2.1 Market Revenue by Product Types:
        2.1.1 Table Market Revenue (in million USD) by Product Types (Historic Data)
        2.1.2 Graph Market Revenue ( in million USD) by Product Types (Current & Forecast Data)
        2.1.3 Graph Market Share (%) by Product Types in 2025

      2.2 Market Volume by Product Types:
        2.2.1 Table Market Volume (in million Units) by Product Types (Historic Data)
        2.2.2 Graph Market Volume ( in million Units) by Product Types (Current & Forecast Data)
        2.2.3 Graph Market Share (%) by Product Types in 2025

      2.3 Lubiprostone
        2.3.1 Graph Global Lubiprostone Revenue (in million USD ) ()
        2.3.2 Graph Global Lubiprostone Volume (in million units ) ()
        2.3.3 Table Lubiprostone Geographical Analysis

      2.4 Linaclotide
        2.4.1 Graph Linaclotide Revenue (in million USD) ()
        2.4.2 Graph Global Linaclotide Volume (in million Units ) ()
        2.4.3 Table Linaclotide Geographical Analysis

            3. Market Segment by Applications
              • Hospitals & Clinics
              • Ambulatory Surgical Centres
              • Long Term Care Centres

              3.1 Table Market Revenue (in million USD) by Application (Historic Data)
              3.2 Table Market Revenue (in million USD) by Application (Current & Forecast Data)
              3.3 Hospitals & Clinics
                3.3.1 Graph Global Hospitals & Clinics Revenue (in million USD ) ()
                3.3.2 Table Global Hospitals & Clinics Geographical Analysis

              3.4 Ambulatory Surgical Centres
                3.4.1 Graph Global AMBULATORY SURGICAL CENTRES Revenue (in million USD ) ()
                3.4.2 Table Global AMBULATORY SURGICAL CENTRES Geographical Analysis

              3.5 Long Term Care Centres

            4 Market by Regions
              • Global Market Revenue (In Million) and Growth Rate Comparison by Regions (2018-2026)
              4.1. North America Chronic Idiopathic Constipation (CIC) Drugs Market Report Analysis()
                4.1.1 USA
                4.1.2 Canada
                4.1.3 Mexico

              4.2 Europe Chronic Idiopathic Constipation (CIC) Drugs Market Report Revenue Forecast (2018-27)
                4.2.1 UK
                4.2.2 Germany
                4.2.3 France
                4.2.4 Italy
                4.2.5 Rest Of Europe

              4.3 APAC Chronic Idiopathic Constipation (CIC) Drugs Market Report Revenue Forecast (2018- 2026)
                4.3.1 China
                4.3.2 Japan
                4.3.3 India
                4.3.4 Singapore
                4.3.5 Malaysia
                4.3.6 Rest Of APAC

              4.4 Rest Of the World (ROW) Market Revenue Forecast (2018-2026)
                4.4.1 Africa
                4.4.2 Middle East
                4.4.3 South America

            5 Competitive Analysis
              5.1 Actavis
                5.1.1 Overview :
                5.1.2 Basic Company Information:
                5.1.3 Financial Overview
                5.1.3 Production Overview
                5.1.4 Geography Revenue Mix ( 2018)
                5.1.5Business Revenue Mix
                5.1.6 Recent Development

              5.2 Chugai Pharmaceutical
                5.2.1 Overview :
                5.2.2 Basic Company Information:
                5.2.3 Financial Overview
                5.2.4 Production Overview
                5.2.5 Geography Revenue Mix ( 2018)
                5.2.6 Business Revenue Mix
                5.2.7 Recent Development

              5. 3 Ferring International Center S.A.
                5.3.1 Overview :
                5.3.2 Basic Company Information:
                5.3.3 Financial Overview
                5.3.4 Production Overview
                5.3.5 Geography Revenue Mix ( 2018)
                5.3.6 Business Revenue Mix
                5.3.7 Recent Development

              5.4 Synergy Pharmaceuticals
                5.4.1 Overview :
                5.4.2 Basic Company Information:
                5.4.3 Financial Overview
                5.4.4 Production Overview
                5.4.5 Geography Revenue Mix ( 2018)
                5.4.6 Business Revenue Mix
                5.4.7 Recent Development

              5.5 Pfizer
              5.6 GlaxoSmithKline
              5.7 Roche Holding AG
              5.8 Sanofi
              5.9 Bayer AG
              5.10 Salix Pharmaceuticals Ltd
              5.11 Sucampo Pharmaceuticals Inc
              5.12 Ironwood Pharmaceuticals
              5.13 Progenics Pharmaceuticals

            6. Research Findings and Conclusion
              6.1 Research Finding:
              6.2 Conclusion:

            7 Methodology and Data Source
              7.1 Methodology/Research Approach
              7.2 Research Programs/Design
              7.3 Market Size Estimation
              7.4 Market Breakdown and Data Triangulation
              7.5 Data Source
              7.5.1 Secondary Sources
              7.5.2 Primary Sources
              7.6 Disclaimer